BIO UV Group (PA:ALTUV) — Stock Price
BIO UV Group (PA:ALTUV) is currently trading at €1.33 EUR, down 2.21% today. Over the past 52 weeks, shares have ranged between €1.22 and €1.82. This page tracks BIO UV Group's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of BIO UV Group.
BIO UV Group (ALTUV) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BIO UV Group's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.
BIO UV Group Income Statement — Revenue, Profit & Earnings by Year
BIO UV Group's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €35.90 Million | €39.58 Million | €43.13 Million | €51.29 Million | €33.46 Million |
| Cost of Revenue | €33.92 Million | €15.49 Million | €17.56 Million | €46.58 Million | €31.62 Million |
| Gross Profit | €2.00 Million | €24.09 Million | €25.58 Million | €4.71 Million | €1.84 Million |
| Research & Development | — | — | €2.89 Million | €2.26 Million | €1.97K |
| SG&A | — | €9.50 Million | €9.77 Million | €9.90 Million | €8.02 Million |
| Total Operating Expenses | €813.73K | €21.96 Million | €23.28 Million | €24.03 Million | €898.60K |
| Operating Income | €1.18 Million | €2.13 Million | €2.30 Million | €4.13 Million | €997.63K |
| EBITDA | €1.60 Million | €4.18 Million | €4.43 Million | €6.38 Million | €3.35 Million |
| EBIT | €-1.20 Million | €867.76K | €1.03 Million | €3.67 Million | €995.61K |
| Interest Expense | €700.00K | €775.48K | €1.02 Million | €677.44K | €364.28K |
| Income Before Tax | €901.70K | €92.29K | €15.54K | €3.00 Million | €631.33K |
| Income Tax Expense | €65.36K | €60.93K | €-109.35K | €577.33K | €-58.05K |
| Net Income | €836.34K | €31.36K | €124.89K | €2.42 Million | €689.38K |
BIO UV Group Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BIO UV Group's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €69.21 Million | €66.09 Million | €71.41 Million | €74.08 Million | €81.12 Million |
| Total Current Assets | €26.58 Million | €23.68 Million | €27.70 Million | €31.02 Million | €35.02 Million |
| Cash & Equivalents | — | €400.00 | €390.00 | €390.00 | €361.07K |
| Short-term Investments | €1.50 Million | €396.00 | €393.00 | €392.00 | €361.07K |
| Net Receivables | €5.31 Million | €3.47 Million | €5.22 Million | €5.21 Million | €5.22 Million |
| Inventory | €10.41 Million | €11.50 Million | €14.76 Million | €19.66 Million | €14.80 Million |
| Property, Plant & Equipment | — | €5.31 Million | €5.22 Million | €3.08 Million | €2.88 Million |
| Goodwill | €31.18 Million | €31.18 Million | €31.18 Million | €31.18 Million | €28.62 Million |
| Total Liabilities | €28.68 Million | €33.40 Million | €39.19 Million | €41.74 Million | €50.43 Million |
| Total Current Liabilities | €12.89 Million | €14.46 Million | €20.89 Million | €18.77 Million | €18.97 Million |
| Long-term Debt | €6.11 Million | €15.84 Million | €14.81 Million | €20.90 Million | €24.58 Million |
| Net Debt | €11.55 Million | €20.12 Million | €25.54 Million | €27.17 Million | €20.52 Million |
| Total Stockholder Equity | €40.47 Million | €32.69 Million | €32.22 Million | €32.24 Million | €30.52 Million |
| Retained Earnings | €836.34K | €31.36K | €124.89K | €2.42 Million | €689.38 |
BIO UV Group Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BIO UV Group generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €4.60 Million | €6.90 Million | €6.24 Million | €2.70 Million | €3.30 Million |
| Capital Expenditures | €1.60 Million | €1.90 Million | €1.96 Million | €2.22 Million | €2.73 Million |
| Free Cash Flow | €3.00 Million | €5.00 Million | €4.28 Million | €476.03K | €571.69K |
| Investing Cash Flow | €-1.60 Million | €-1.87 Million | €-1.95 Million | €-8.95 Million | €-20.70 Million |
| Financing Cash Flow | €3.40 Million | €-3.73 Million | €-3.57 Million | €-2.50 Million | €15.53 Million |
| Dividends Paid | — | — | €607.07K | €505.24K | €505.24K |
| Stock-Based Compensation | — | — | — | €-242.37K | €-4.70 Million |
| Depreciation | €2.80 Million | €3.20 Million | €3.40 Million | €2.89 Million | €2.35 Million |
| Change in Cash | €-3.87 Million | €1.39 Million | €731.25K | €-8.82 Million | €-1.73 Million |
BIO UV Group Earnings History — EPS Actual vs. Analyst Estimates
Track BIO UV Group's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 01, 2026 | — | — | — |
| Sep 18, 2025 | 0.10 | 0.00 | — |
| Apr 29, 2025 | -0.03 | 0.00 | — |
| Jan 22, 2025 | — | — | — |
| Nov 27, 2024 | 0.00 | 0.00 | — |
| Sep 20, 2024 | 0.04 | 0.00 | — |
| Apr 03, 2024 | 0.00 | 0.00 | — |
| Nov 29, 2023 | 0.00 | 0.00 | — |